Georgia Cataract & Eye Specialty Center

Call 770-834-1008
Schedule

EVO ICL Surgery in Georgia

EVO ICL™ Lens

At Georgia Vision Institute, our highest priority is making sure our patients have healthy eyes and clear vision. We offer a full range of vision correction options, including EVO ICL lens (EVO) for our patients who want to break free from the hassles of glasses and contacts.

What is EVO ICL?

EVO ICL, also called an Implantable Collamer® Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) with or without astigmatism. Unlike some other vision correction options, the EVO ICL is an additive technology that corrects vision without the removal of any corneal tissue. The EVO ICL is meant to reduce or eliminate the need for glasses and contact lenses and unlike most permanent refractive surgery solutions, EVO ICL is removable by your doctor, for added peace of mind.

EVO ICL Procedure: What to Expect

EVO ICL is made of biocompatible Collamer material that works in harmony with your eye. Your eye doctor will create a small opening in your cornea that will be used to insert and position the EVO ICL in front of the natural lens of your eye. For most patients, the procedure is virtually painless with anesthetic eye drops and it typically takes less than 20 – 30 minutes.

Easy 20-30 Minute Surgical Procedure

Pre-Op
Eye Exam
Eye Drops
Administered
Small
Opening
Lens Insertion
and Positioning
Post Op &
Check-up

What is Recovery Like after EVO ICL?

Eyeglasses

Most patients notice a dramatic improvement in their vision nearly immediately after their EVO ICL vision correction surgery. Recovery is brief and comfortable, with many patients returning to work the very next day.

Benefits of EVO ICL

  • Provides sharp, clear vision1, 2
  • 20 to 30 minute procedure
  • Quick recovery time
  • Removable by your ophthalmologist
  • Offers UV protection
  • Not visible once in place
  • For patients who may not be candidates for LASIK or other vision correction procedures due to thin corneas 3
  • 99.4% of patients surveyed would have the EVO ICL lens procedure again7
  • Can treat nearsightedness (myopia) with or without astigmatism
  • Does not cause or worsen dry eye syndrome4, 5
  • Exceptional vision both day and night6
  • Over 2 million ICLs distributed world-wide

Cost and Financing for EVO ICL

The cost of an EVO ICL procedure can vary depending on your personalized treatment plan. Many EVO ICL patients look forward to spending less in the long run with the EVO ICL compared to the continued costs of contact lenses and glasses. Ask about financing options and payment plans that may be available for your EVO ICL procedure.

Contact Lenses

Am I a Good Candidate for EVO ICL?

EVO ICL is well-suited for a wide variety of people. Ideal candidates for EVO ICL are
aged 21 to 45 with nearsightedness (myopia) with or without astigmatism and have maintained a stable prescription for at least one year. Candidates should also have healthy eyes with no history of eye conditions such as glaucoma. If you are seeking a solution to decrease or eliminate the cost and frustration of traditional contact lenses or glasses, EVO ICL may be your answer. Contact us to discuss if refractive surgery with EVO ICL is right for you.

EVO ICL

The EVO ICL (Implantable Collamer Lens) is an implant that corrects vision without removing any corneal tissue.

LASIK

LASIK is a two-step laser vision correction surgery where a flap is made on the surface of the eye called the cornea, and the underlying layers are reshaped with an
excimer laser to correct vision.

PRK

PRK is a laser vision procedure similar to LASIK but no corneal flap is created. The top layer of the cornea called the epithelium is removed, and the underlying tissue is reshaped to correct vision.

Am I a Good Candidate for EVO ICL?

This chart breaks down the general candidacy guidelines for each procedure. During your initial consultation, your eye care professional will discuss your measurements and help you make the right choice depending on your unique vision.


 EVO ICL
 LASIK
 PRK
Nearsightedness
 Moderate to Severe
 Mild to Moderate
 Mild to Moderate
Farsightedness
 No
 Yes
 Yes
Astigmatism
 Yes
 Yes
 Yes
Thin Cornea
 Yes 8
 Limited
 Limited
Important Safety Information

The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before. Since implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if your doctor determines that 1) the shape of your eye is not appropriate, 2) you do not meet the minimum endothelial cell density for your age at the time of implantation, 3) you have moderate to severe glaucoma, 4) your vision is not stable; or 5) if you are pregnant or nursing. For additional information with potential benefits, risks and complications please visit DiscoverICL.com

 

  1. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
  2. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.
  3. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
  4. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.
  5. Naves J.S, Carracedo G, Cacho-Babillo I. Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
  6. Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117–125.
  7. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
  8. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.